1970Stamford Journal of Pharmaceutical SciencesOpen access

Simultaneous Estimation of Naproxen and Ranitidine HCl by Using UV Spectrophotometer

Tasnuva Haque, Mesbah Talukder, Susmita Laila, Kanij Fatema, Abdul Kalam Lutful Kabir

Open full text 14 citations

Abstract

The development of a UV Spectrophotometric method for simultaneous estimation of Ranitidine HCl and Naproxen involves absorbance measurement of Ranitidine HCl at 313 nm in pH 7.4 phosphate buffer and 314 nm in both 0.1N HCl and in water and that of Naproxen at 229 nm in pH 7.4 phosphate buffer and 232 nm in both 0.1N HCl and in water corresponding to the respective absorption maxima. Both the drugs obey Beer- Lambert's law in the range of 5-25 μg/ml for Ranitidine HCl and 0.2-1.25 μg/ml for Naproxen. The method developed was validated to determine its linearity, precision, reproducibility and sensitivity. The tablet formulations were evaluated for the percent content of both the drugs at the selected wavelengths and the percent potency were 98.83 and 99.15 for Naproxen and Ranitidine HCl respectively. Key words: Naproxen, Ranitidine HCl, Ultraviolet spectroscopy, marketed products.doi:10.3329/sjps.v1i1.1781 S. J. Pharm. Sci. 1(1&2): 18-24

Open-access reader

About this research paper

What this paper is about

The development of a UV Spectrophotometric method for simultaneous estimation of Ranitidine HCl and Naproxen involves absorbance measurement of Ranitidine HCl at 313 nm in pH 7.4 phosphate buffer and 314 nm in both 0.1N HCl and in water and that of Naproxen at 229 nm in pH 7.4 phosphate buffer and 232 nm in both 0.1N HCl and in water corresponding to the respective absorption maxima. Both the drugs obey Beer- Lambert's law in the range of 5-25 μg/ml for Ranitidine HCl and 0.2-1.25 μg/ml for Naproxen. The method developed was validated to determine its linearity, precision, reproducibility and sensitivity. The tablet formulations were evaluated for the percent content of both the drugs at the selected wavelengths and the percent potency were 98.83 and 99.15 for Naproxen and Ranitidine HCl respectively. Key words: Naproxen, Ranitidine HCl, Ultraviolet spectroscopy, marketed products.doi:10.3329/sjps.v1i1.1781 S. J. Pharm. Sci. 1(1&2): 18-24

Why it matters

OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The development of a UV Spectrophotometric method for simultaneous estimation of Ranitidine HCl and Naproxen involves absorbance measurement of Ranitidine HCl at 313 nm in pH 7.4 phosphate buffer and 314 nm in both 0.1N HCl and in water and that of Naproxen at 229 nm in pH 7.4 phosphate buffer and 232 nm in both 0.1N HCl and in water corresponding to the respective absorption maxima. Both the drugs obey Beer- Lambert's law in the range of 5-25 μg/ml for Ranitidine HCl and 0.2-1.25 μg/ml for Naproxen. The method developed was validated to determine its linearity, precision, reproducibility and sensitivity. The tablet formulations were evaluated for the percent content of both the drugs at the selected wavelengths and the percent potency were 98.83 and 99.15 for Naproxen and Ranitidine HCl respectively. Key words: Naproxen, Ranitidine HCl, Ultraviolet spectroscopy, marketed products.doi:10.3329/sjps.v1i1.1781 S. J. Pharm. Sci. 1(1&2): 18-24

Key concepts: Naproxen, Chemistry, Ranitidine, Phosphate buffered saline, Chromatography, Absorbance, Reproducibility, Spectrophotometry

Related papers

Back to paper searchBrowse research topicsOriginal source
Simultaneous Estimation of Naproxen and Ranitidine HCl by Using UV Spectrophotometer — Research Paper | ScholarLens